Stem Cell Research (May 2021)

CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM)

  • Anna Janz,
  • Miriam Zink,
  • Alexandra Cirnu,
  • Annika Hartleb,
  • Christina Albrecht,
  • Simone Rost,
  • Eva Klopocki,
  • Katharina Günther,
  • Frank Edenhofer,
  • Süleyman Ergün,
  • Brenda Gerull

Journal volume & issue
Vol. 53
p. 102256

Abstract

Read online

Arrhythmogenic cardiomyopathy (ACM) is characterized by fibro-fatty replacement of the myocardium, heart failure and life-threatening ventricular arrhythmias. Causal mutations were identified in genes encoding for proteins of the desmosomes, predominantly plakophilin-2 (PKP2) and desmoglein-2 (DSG2). We generated gene-edited knock-out iPSC lines for PKP2 (JMUi001-A-2) and DSG2 (JMUi001-A-3) using the CRISPR/Cas9 system in a healthy control iPSC background (JMUi001-A). Stem cell-like morphology, robust expression of pluripotency markers, embryoid body formation and normal karyotypes confirmed the generation of high quality iPSCs to provide a novel isogenic human in vitro model system mimicking ACM when differentiated into cardiomyocytes.